AAAAAA
Results: 1-25/37
Authors:
PETITJEAN O
Citation: O. Petitjean, PHARMACOKINETICS OF CIPROFLOXACIN, La Presse medicale, 27(14), 1998, pp. 690-692
Authors:
MIMOZ O
BINTER V
JACOLOT A
EDOUARD A
TOD M
PETITJEAN O
SAMII K
Citation: O. Mimoz et al., PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILTY OF CIPROFLOXACIN ADMINISTERED THROUGH A NASOGASTRIC TUBE WITH CONTINUOUS ENTERAL FEEDING TO CRITICALLY ILL PATIENTS, Intensive care medicine, 24(10), 1998, pp. 1047-1051
Authors:
NICOLAS P
TOD M
PADOIN C
PETITJEAN O
Citation: P. Nicolas et al., CLINICAL PHARMACOKINETICS OF DIACEREIN, Clinical pharmacokinetics, 35(5), 1998, pp. 347-359
Authors:
MIMOZ O
JACOLOT A
PADOIN C
TOD M
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., CEFEPIME AND AMIKACIN SYNERGY IN-VITRO AND IN-VIVO AGAINST A CEFTAZIDIME-RESISTANT STRAIN OF ENTEROBACTER-CLOACAE, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 367-372
Authors:
PADOIN C
TOD M
PERRET G
PETITJEAN O
Citation: C. Padoin et al., ANALYSIS OF THE PHARMACOKINETIC INTERACTION BETWEEN CEPHALEXIN AND QUINAPRIL BY A NONLINEAR MIXED-EFFECT MODEL, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1463-1469
Authors:
TOD M
LORTHOLARY O
SEYTRE D
SEMAOUN R
UZZAN B
GUILLEVIN L
CASASSUS P
PETITJEAN O
Citation: M. Tod et al., POPULATION PHARMACOKINETIC STUDY OF AMIKACIN ADMINISTERED ONCE OR TWICE-DAILY TO FEBRILE, SEVERELY NEUTROPENIC ADULTS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 849-856
Authors:
TOD M
PETITJEAN O
LORTHOLARY O
Citation: M. Tod et al., THERAPEUTIC MONITORING OF GLYCOPEPTIDES - WHY AND HOW, Medecine et maladies infectieuses, 27, 1997, pp. 954-957
Authors:
PETITJEAN O
Citation: O. Petitjean, INHIBITORY QUOTIENT (IQ) - MYTH OR REALIT Y, Medecine et maladies infectieuses, 27, 1997, pp. 958-961
Authors:
LORTHOLARY O
TOD M
DURANDGASSELIN B
GUILLEVIN L
PETITJEAN O
CASASSUS P
Citation: O. Lortholary et al., USING GLYCOPEPTIDES IN FEBRILE NEUTROPENI C ADULTS, Medecine et maladies infectieuses, 27, 1997, pp. 979-983
Authors:
MIMOZ O
JACOLOT A
PADOIN C
CAILLON J
LOUCHAHI K
TOD M
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., CEFEPIME AND AMIKACIN SYNERGY AGAINST A CEFOTAXIME-SUSCEPTIBLE STRAINOF ENTEROBACTER-CLOACAE IN-VITRO AND IN-VIVO, Journal of antimicrobial chemotherapy, 39(3), 1997, pp. 363-369
Authors:
TOD M
ALET P
LORTHOLARY O
PETITJEAN O
Citation: M. Tod et al., IMPLEMENTATION AND EVALUATION OF A STOCHASTIC-CONTROL STRATEGY FOR INDIVIDUALIZING TEICOPLANIN DOSAGE REGIMEN, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 695-712
Authors:
JACOLOT A
TOD M
HEUDES AM
PETITJEAN O
LAROCHE L
Citation: A. Jacolot et al., MONITORING OF 8-METHOXYPSORALEN DURING EXTRACORPOREAL PHOTOCHEMOTHERAPY - EVIDENCE FOR A FIRST-DOSE EFFECT, Therapeutic drug monitoring, 18(3), 1996, pp. 234-239
Authors:
LORTHOLARY O
TOD M
RIZZO N
PADOIN C
BIARD O
CASASSUS P
GUILLEVIN L
PETITJEAN O
Citation: O. Lortholary et al., POPULATION PHARMACOKINETIC STUDY OF TEICOPLANIN IN SEVERELY NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1242-1247
Authors:
JACOLOT A
TOD M
PETITJEAN O
Citation: A. Jacolot et al., PHARMACOKINETIC INTERACTION BETWEEN CEFDINIR AND 2 ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN RATS, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 979-982
Authors:
TOD M
PADOIN C
MINOZZI C
COUGNARD J
PETITJEAN O
Citation: M. Tod et al., POPULATION PHARMACOKINETIC STUDY OF ISEPAMICIN WITH INTENSIVE-CARE UNIT PATIENTS, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 983-987
Authors:
MIMOZ O
JACOLOT A
PADOIN C
QUILLARD J
TOD M
LOUCHAHI K
SAMII K
PETITJEAN O
Citation: O. Mimoz et al., INFLUENCE OF EXPERIMENTAL RAT MODEL OF MULTIPLE ORGAN DYSFUNCTION ON CEFEPIME AND AMIKACIN PHARMACOKINETICS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 819-821
Authors:
LOUCHAHI K
TOD M
BONNARDEL P
PETITJEAN O
Citation: K. Louchahi et al., DETERMINATION OF PIRACETAM IN HUMAN PLASMA AND URINE BY LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 663(2), 1995, pp. 385-389
Authors:
PETITJEAN O
TOD M
LOUCHAHI K
Citation: O. Petitjean et al., INFLUENCE OF METHODOLOGICAL ASPECTS ON TISSUE DRUG CONCENTRATION ESTIMATION, Journal of pharmaceutical and biomedical analysis, 13(7), 1995, pp. 817-822
Authors:
PETITJEAN O
JACOLOT A
TOD M
Citation: O. Petitjean et al., SYSTEMIC ANTIFUNGAL AZOLES PHARMACOLOGY, Medecine et maladies infectieuses, 25(BIS), 1995, pp. 14-26
Authors:
PETITJEAN O
JACOLOT A
TOD M
Citation: O. Petitjean et al., SYSTEMIC ANTIFUNGAL AZOLES PHARMACOLOGY, Medecine et maladies infectieuses, 25, 1995, pp. 14-26
Authors:
TOD M
POBEL C
LEGROS V
LOUCHAHI K
PETITJEAN O
BRION N
GARCIAMACE JL
Citation: M. Tod et al., A POPULATION PHARMACOKINETIC STUDY OF ALMINOPROFEN PENETRATION INTO SYNOVIAL-FLUID, Biopharmaceutics & drug disposition, 16(8), 1995, pp. 627-634
Authors:
PADOIN C
TOD M
BRION N
LOUCHAHI K
LEGROS V
PETITJEAN O
Citation: C. Padoin et al., PHARMACOKINETICS OF AMOXICILLIN COADMINISTERED WITH A SALINE POLYETHYLENE-GLYCOL SOLUTION IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 16(3), 1995, pp. 169-176
Authors:
ELMANSOURI S
TOD M
LECLERQ M
PETITJEAN O
PERRET G
PORTHAULT M
Citation: S. Elmansouri et al., TIME-DEPENDENT AND DOSE-DEPENDENT KINETICS OF ALL-TRANS-RETINOIC ACIDIN RATS AFTER ORAL OR INTRAVENOUS ADMINISTRATION(S), Drug metabolism and disposition, 23(2), 1995, pp. 227-231
Authors:
THALER F
BERNARD B
TOD M
JEDYNAK CP
PETITJEAN O
DEROME P
Citation: F. Thaler et al., FLUCONAZOLE PENETRATION IN CEREBRAL PARENCHYMA IN HUMANS AT STEADY-STATE, Antimicrobial agents and chemotherapy, 39(5), 1995, pp. 1154-1156
Authors:
LORTHOLARY O
TOD M
COHEN Y
PETITJEAN O
Citation: O. Lortholary et al., AMINOGLYCOSIDES, The Medical clinics of North America, 79(4), 1995, pp. 761-787